{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T20:52:31Z","timestamp":1785185551880,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":1622,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1136\/ijgc-2020-001263","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T06:14:42Z","timestamp":1588745682000},"page":"1177-1182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Patient-initiated follow-up after treatment for low risk endometrial cancer: a prospective audit of outcomes and cost benefits"],"prefix":"10.1016","volume":"30","author":[{"given":"Sarah","family":"Coleridge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0000-520X","authenticated-orcid":false,"given":"Jo","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2020-001263_bb0010","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/bjc.2012.366","article-title":"Projections of cancer prevalence in the United Kingdom, 2010-2040","volume":"107","author":"Maddams","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2020-001263_bb0015","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/bjc.2011.416","article-title":"The National Cancer Survivorship Initiative: new and emerging evidence on the ongoing needs of cancer survivors","volume":"105","author":"Richards","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2020-001263_bb0020","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/cncr.31165","article-title":"Risk of recurrence, prognosis, and follow-up for Danish women with cervical cancer in 2005-2013: a national cohort study","volume":"124","author":"Taarnh\u00f8j","year":"2018","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2020-001263_bb0025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/gyno.1994.1282","article-title":"An evaluation of routine follow-up of patients treated for endometrial carcinoma","volume":"55","author":"Shumsky","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001263_bb0030","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1471-0528.1997.tb10979.x","article-title":"Recurrence of endometrial carcinoma and the value of routine follow up","volume":"104","author":"Salvesen","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1136\/ijgc-2020-001263_bb0035","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ygyno.2006.02.011","article-title":"Follow-up after primary therapy for endometrial cancer: a systematic review","volume":"101","author":"Fung-Kee-Fung","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001263_bb0040","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/IGC.0b013e3181e2abcc","article-title":"Surveillance procedures for patients treated for endometrial cancer: a review of the literature","volume":"20","author":"Sartori","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-001263_bb0045","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/1471-0528.14000","article-title":"Comparing hospital and telephone follow-up for patients treated for stage-I endometrial cancer (ENDCAT trial): a randomised, multicentre, non-inferiority trial","volume":"124","author":"Beaver","year":"2017","journal-title":"BJOG"},{"key":"10.1136\/ijgc-2020-001263_bb0050","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ejogrb.2017.01.025","article-title":"The future for follow-up of gynaecological cancer in Europe. summary of available data and overview of ongoing trials","volume":"210","author":"Leeson","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1136\/ijgc-2020-001263_bb0055","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1111\/1471-0528.15396","article-title":"Patient-Initiated follow up affects fear of recurrence and healthcare use: a randomised trial in early-stage endometrial cancer","volume":"125","author":"Jeppesen","year":"2018","journal-title":"BJOG"},{"key":"10.1136\/ijgc-2020-001263_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2019.101704","article-title":"Exploring the acceptability and feasibility of patient-initiated follow-up for women treated for stage I endometrial cancer","volume":"44","author":"Beaver","year":"2020","journal-title":"Eur J Oncol Nurs"},{"key":"10.1136\/ijgc-2020-001263_bb0065","article-title":"Acceptability and utilisation of patient-initiated follow-up for endometrial cancer amongst women from diverse ethnic and social backgrounds: a mixed methods study","volume":"28","author":"Kumarakulasingam","year":"2019","journal-title":"Eur J Cancer Care"},{"key":"10.1136\/ijgc-2020-001263_bb0070","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0959-8049(01)00066-1","article-title":"Value and cost evaluation of routine follow-up for patients with clinical stage I\/II endometrial cancer","volume":"37","author":"Morice","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2020-001263_bb0075","first-page":"931","author":"Tjalma","year":"2004","journal-title":"The clinical value and the cost-effectiveness of follow-up in endometrial cancer patients"},{"key":"10.1136\/ijgc-2020-001263_bb0080","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s40258-018-0378-6","article-title":"Cost-consequence analysis alongside a randomised controlled trial of hospital versus telephone follow-up after treatment for endometrial cancer","volume":"16","author":"Dixon","year":"2018","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1136\/ijgc-2020-001263_bb0085","author":"Department of Health","year":"2010","journal-title":"The National Cancer Survivorship Initiative Vision."},{"key":"10.1136\/ijgc-2020-001263_bb0090","author":"Department of Health","year":"2013","journal-title":"Living with & beyond cancer: taking action to improve outcomes (an update to the 2010 the National Cancer Survivorship Initiative Vision)"},{"key":"10.1136\/ijgc-2020-001263_bb0095","author":"Rowe","year":"2014"},{"key":"10.1136\/ijgc-2020-001263_bb0100","article-title":"Lymphadenectomy for the management of endometrial cancer","volume":"10","author":"Frost","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1136\/ijgc-2020-001263_bb0105","doi-asserted-by":"crossref","first-page":"vi35","DOI":"10.1093\/annonc\/mdr374","article-title":"Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"22","author":"Colombo","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2020-001263_bb0110","author":"National Health Service Improvement","year":"2019"},{"key":"10.1136\/ijgc-2020-001263_bb0115","year":"2019","journal-title":"Google maps"},{"key":"10.1136\/ijgc-2020-001263_bb0120","author":"Ivashchenko","year":"2019"},{"key":"10.1136\/ijgc-2020-001263_bb0125","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1080\/0284186X.2016.1267396","article-title":"Detection of recurrence in early stage endometrial cancer - the role of symptoms and routine follow-up","volume":"56","author":"Jeppesen","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1136\/ijgc-2020-001263_bb0130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejogrb.2017.04.015","article-title":"BGCS uterine cancer guidelines: recommendations for practice","volume":"213","author":"Sundar","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1136\/ijgc-2020-001263_bb0135","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2020-001263_bb0140","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","article-title":"Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis","volume":"373","author":"ASTEC\/EN.5 Study Group","year":"2009","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2020-001263_bb0145","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","article-title":"Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study","volume":"373","author":"ASTEC study group","year":"2009","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2020-001263_bb0150","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2020-001263_bb0155","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/aogs.13199","article-title":"A national, prospective observational study of first recurrence after primary treatment for gynecological cancer in Norway","volume":"96","author":"Vistad","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1136\/ijgc-2020-001263_bb0160","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1136\/ijgc-00009577-200609000-00003","article-title":"Mode of detection of recurrent gynecological malignancy: does routine follow-up delay diagnosis and treatment?","volume":"16","author":"Nordin","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-001263_bb0165","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/01443610802646801","article-title":"Patients' views of follow-up after treatment for gynaecological cancer","volume":"29","author":"Kew","year":"2009","journal-title":"J Obstet Gynaecol"},{"key":"10.1136\/ijgc-2020-001263_bb0170","first-page":"1077","article-title":"Financial and family burden associated with cancer treatment in Ontario, Canada","volume":"14","author":"Longo","year":"2006","journal-title":"Support Care Cancer"},{"key":"10.1136\/ijgc-2020-001263_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2020.101722","article-title":"Endometrial cancer patients' preferences for follow-up after treatment: a cross-sectional survey","volume":"45","author":"Beaver","year":"2020","journal-title":"Eur J Oncol Nurs"},{"key":"10.1136\/ijgc-2020-001263_bb0180","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/ijgc-2019-001176","article-title":"British gynaecological cancer Society recommendations and guidance on patient-initiated follow-up (PIFU)","volume":"30","author":"Newton","year":"2020","journal-title":"Int J Gynecol Cancer"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25000337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25000337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2020-001263","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:25:44Z","timestamp":1753233944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X25000337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1048891X25000337"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2020-001263","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-initiated follow-up after treatment for low risk endometrial cancer: a prospective audit of outcomes and cost benefits","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2020-001263","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}